Medical News

RSS

UHC signs strategic partnership agreement with EHR

The University HealthSystem Consortium (UHC) and Executive Health Resources, Inc. (EHR) today announced the signing of a strategic partnership that will make EHR's expert Physician Advisor solutions available to all UHC members.

6 Jan 2010

Animal experiments show old antidepressant may reverse heart failure

A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

6 Jan 2010

Excaliard Pharmaceuticals initiates Phase 2 trials of EXC 001

Excaliard Pharmaceuticals, Inc. announced today the initiation of three proof of concept Phase 2 trials of EXC 001, an antisense medicine that reduces fibrosis, for the amelioration of skin scarring and other fibrotic disorders.

6 Jan 2010

New research may yield more effective treatment for childhood leukemia

A team of Israeli scientists at the Sheba Medical Center's Research Center for Leukemia and Childhood Malignancies has discovered a method for developing a more effective and less perilous treatment for those suffering from childhood leukemia, the most common cancer in children.

6 Jan 2010

Health Sciences Group negotiates with The Healing Center for Medical Marijuana license in Colorado

Health Sciences Group, Inc. would like to announce that it has engaged in negotiations with The Healing Center to assist with the acquisition of a Medical Marijuana license in the State of Colorado.

6 Jan 2010

Medizone International completes third round of testing and data logging for AsepticSure technology

Medizone International, Inc. announces that its third round of testing and data logging for the enhanced AsepticSure(TM) technology is now complete.

6 Jan 2010

Intuity Medical secures $64M Series D financing round

Intuity Medical, Inc., a privately-held company developing innovative technologies in diabetes management, today announced that it has secured a $64M Series D financing round.

6 Jan 2010

Medicare begins to reimburse for HIV screening

The Hartford Courant reports that "testing for the virus among those 65 and older lags far behind testing of other Americans, and experts say they worry that HIV cases in older adults go undiagnosed — some because of the stigma that the disease still carries, some because patients might dismiss the symptoms of the virus as signs of other conditions more frequently associated with aging and some because doctors can be hesitant to talk to older patients about sex or link their symptoms with HIV."

6 Jan 2010

EnVivo Pharmaceuticals announces initiation and dosing of patients in Phase 2b study of EVP-6124

EnVivo Pharmaceuticals today announced the initiation and dosing of patients in a Phase 2b study of its EVP-6124 compound, a selective alpha-7 nicotinic agonist in patients with schizophrenia. EnVivo is conducting the multi-center, dose ranging, placebo controlled, three-month study in the U.S. and Europe.

6 Jan 2010

NFCA and Partners Against Pain team up to create new Caregiver Cornerstones resource

The National Family Caregivers Association (NFCA) has teamed up with the national pain management education program, Partners Against Pain®, and advocate and author Lee Woodruff to create the new Caregiver Cornerstones resource.

6 Jan 2010

Sonova completes acquisition of Insound Medical, sees growth potential in Lyric brand of hearing systems

Sonova Holding AG, the world’s leading provider of hearing systems, announced today that it has successfully completed its acquisition of InSound Medical Inc., Newark, USA. InSound Medical developed the first extended wear hearing system which is placed deep in the ear canal and totally invisible from the outside, and markets it under the Lyric® brand.

6 Jan 2010

Biomet reports second quarter financial results for fiscal 2010

Biomet, Inc. net sales increased 8% during the second fiscal quarter ended November 30, 2009, to $695.6 million from $642.8 million during the second quarter of fiscal year 2009. On a constant currency basis, net sales increased 5% during the second quarter of fiscal 2010.

6 Jan 2010

Study indicates efficacy of antidepressants varies significantly depending on symptom severity

An analysis of randomized trials indicates that compared with placebo, the magnitude of benefit of antidepressant medications varies with the severity of depressive symptoms, and may provide little benefit for patients with mild or moderate depression, but appear to provide substantial benefit for patients with very severe depression, according to an article in the January 6 issue of JAMA.

6 Jan 2010

Lerner Medical Devices' Levia receives FDA clearance

Lerner Medical Devices, Inc. announced today that Levia®, a novel, in-home, ultraviolet B (UVB) phototherapy device, has received 510 (k) clearance from the U.S. Food and Drug Administration (FDA) for treatment of psoriasis and certain other skin conditions such as vitiligo.

6 Jan 2010

Biotime ships six ACTCellerate progenitor cell lines to Millipore

BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.

6 Jan 2010

Health Canada approves Zyclara Cream for multiple actinic keratoses

Health Canada has approved Zyclara™ (imiquimod) Cream 3.75%, a topical prescription treatment for multiple actinic keratoses (AK) located on the face or balding scalp in adults. Actinic Keratosis is a common skin condition that can lead to squamous cell carcinoma, a form of non-melanoma skin cancer, if left untreated.

6 Jan 2010

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

Bioheart, Inc. announced today that the company has signed distribution agreements with Restoration Medical, McRay Medical, Alamo Scientific and Morey Medical. These distributors will assist Bioheart with introducing its Home Heart Failure Monitoring Systems to physicians and hospitals throughout the United States.

6 Jan 2010

States that receive federal funds are more likely to implement obesity-prevention programs

States that received funding from two obesity prevention programs founded by the U.S. Centers for Disease Control & Prevention implemented more than twice as many obesity-prevention policy initiatives as states that did not receive funding, according to a study by researchers from RTI International.

6 Jan 2010

Excessive reduction of fat mass in girls may increase risk of osteoporosis in later life

According to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM), fat mass is important in increasing bone size and thickness, but this effect appears to be stronger in girls than boys.

6 Jan 2010

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.

6 Jan 2010

Medical News

UHC signs strategic partnership agreement with EHR

Animal experiments show old antidepressant may reverse heart failure

Excaliard Pharmaceuticals initiates Phase 2 trials of EXC 001

New research may yield more effective treatment for childhood leukemia

Health Sciences Group negotiates with The Healing Center for Medical Marijuana license in Colorado

Medizone International completes third round of testing and data logging for AsepticSure technology

Intuity Medical secures $64M Series D financing round

Medicare begins to reimburse for HIV screening

EnVivo Pharmaceuticals announces initiation and dosing of patients in Phase 2b study of EVP-6124

NFCA and Partners Against Pain team up to create new Caregiver Cornerstones resource

Sonova completes acquisition of Insound Medical, sees growth potential in Lyric brand of hearing systems

Biomet reports second quarter financial results for fiscal 2010

Study indicates efficacy of antidepressants varies significantly depending on symptom severity

Lerner Medical Devices' Levia receives FDA clearance

Biotime ships six ACTCellerate progenitor cell lines to Millipore

Health Canada approves Zyclara Cream for multiple actinic keratoses

Bioheart signs distribution agreements to market Home Heart Failure Monitoring Systems in U.S.

States that receive federal funds are more likely to implement obesity-prevention programs

Excessive reduction of fat mass in girls may increase risk of osteoporosis in later life

IBI initiates Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News